Why does gut health affect so much more than digestion?

What does the gut actually do beyond digesting food?

Beyond digestion, the gut regulates immunity, makes and processes neurotransmitters and hormones, extracts and synthesizes nutrients, guards the barrier between gut contents and the bloodstream, and talks to the brain through the vagus nerve. The gut serves multiple functions that go far beyond breaking down meals:

• Immune regulation. Roughly 70% of the body's immune cells reside in gut-associated lymphoid tissue. The gut is constantly distinguishing between harmless food, beneficial bacteria, and threats, calibrating immune responses across the whole body
• Neurotransmitter production. Roughly 90% of the body's serotonin and 50% of its dopamine are produced in the gut. These neurotransmitters affect mood, sleep, appetite, and cognition
• Hormone metabolism. The gut microbiome metabolizes estrogen, thyroid hormones, and other endocrine signals, affecting how much active hormone reaches tissues
• Nutrient extraction and synthesis. Beyond absorbing nutrients, gut bacteria synthesize B vitamins, vitamin K, and short-chain fatty acids that affect metabolism throughout the body
• Barrier function. The single-cell-thick intestinal lining controls what passes from the gut into systemic circulation. When that barrier becomes more permeable than it should be, immune activation and inflammation follow
• Communication with the brain. The vagus nerve (the main communication highway between gut and brain) carries signals continuously, with roughly 80% running from gut to brain rather than the other way

What is the gut microbiome, and why does it matter?

The gut microbiome is the trillions of bacteria, fungi, viruses, and other organisms living in the intestines, particularly the large intestine. Composition shifts with diet, medications, stress, sleep, illness, age, and many other factors.

Specific bacterial profiles influence calorie extraction from food, short-chain fatty acid production, immune regulation, neurotransmitter availability, hormone metabolism, and inflammatory tone. Particular bacterial families have been associated with metabolic health, cognitive function, mood, and disease risk.

The science is still evolving. The microbiome matters; what's less established is which specific interventions reliably shift composition in ways that produce predictable clinical outcomes. The principles (diverse fiber-rich diet, limited antibiotics when avoidable, fermented foods, addressing dysbiosis when present) are well-supported. The detailed protocols are still being developed.

What are the most common gut conditions and patterns?

The most common patterns are IBS, small intestinal bacterial overgrowth and its methane variant, increased intestinal permeability, food sensitivities, reflux, inflammatory bowel disease and dysbiosis. Several gut patterns show up repeatedly in clinical practice:

• IBS (irritable bowel syndrome). A pattern of bloating, gas, abdominal pain, and altered bowel habits affecting roughly 6% of the population
• SIBO (small intestinal bacterial overgrowth). Bacteria that belong in the colon migrate to or overgrow in the small intestine. Found in roughly a third of IBS cases on meta-analysis (35.5% by breath testing), with the odds of SIBO about 3.7 times higher in IBS than in controls [PMID: 31913194]
• IMO (intestinal methanogen overgrowth). The methane-producing variant of small intestine overgrowth, often presenting as constipation
• Increased intestinal permeability (the term replacing the older "leaky gut"). Gut lining becomes more permeable than it should be, allowing partially digested food and bacterial components into circulation
• Food sensitivities. Immune-mediated reactions to specific foods, distinct from allergies
• GERD/reflux. Often related to low stomach acid rather than excess
• IBD (inflammatory bowel disease, including Crohn's and ulcerative colitis). Autoimmune conditions requiring specialty care
• Dysbiosis. Imbalanced microbiome composition

The same symptom (bloating, for instance) can come from any of several different patterns. Diagnostic precision matters.

What's the difference between conventional GI care and a precision medicine approach?

The difference is scope: conventional gastroenterology is built to find and treat structural disease, while a precision approach adds functional testing and root-cause investigation for the symptoms that remain once structural disease has been ruled out. Conventional gastroenterology focuses on diagnosing structural disease (IBD, GERD, malignancy) and managing symptoms (PPIs, laxatives, antispasmodics, prokinetics). This care is essential for the conditions it addresses.

A precision medicine approach combines structural assessment with functional investigation, microbiome analysis, and addressing root causes. It typically asks why the gut is dysfunctional rather than just naming the symptom pattern (IBS) and managing it. The two approaches are complementary; structural disease still needs gastroenterology, but the broader category of functional gut symptoms often benefits from a wider workup.

What labs and tests reveal what's happening in the gut?

The tests that reveal what is happening in the gut are a comprehensive stool analysis, a SIBO breath test, permeability markers, H. pylori testing, an organic acids panel and, depending on history, a structured food-sensitivity assessment and pancreatic or biliary studies. A useful gut workup typically includes:

• Comprehensive stool analysis. Assesses microbiome composition, markers of digestive function, inflammatory markers, and pathogens
• SIBO breath testing. Lactulose or glucose breath test, measuring hydrogen and methane production after the test substrate
• Food sensitivity assessment. A structured food and symptom history with supervised elimination and reintroduction; blood IgG panels are not validated for diagnosis, because the antibodies they measure mainly reflect exposure to a food [PMID: 22835332]
• Gut permeability markers. Zonulin (a protein that regulates the tight junctions between gut cells), lipopolysaccharides (LPS, fragments of bacterial cell walls in circulation)
• H. pylori testing
• Organic acids panel. Captures markers of bacterial and fungal overgrowth from urine
• Depending on history: parasitology, stool elastase (for pancreatic enzyme insufficiency), pancreatic and biliary studies

What are the most common drivers of gut dysfunction?

The most common drivers are antibiotic exposure, chronic stress, low stomach acid, food sensitivities, specific infections, medication effects, a low-fiber and ultra-processed diet, environmental exposures and chronic inflammation from any source. Several factors repeatedly contribute to gut dysfunction:

• Antibiotic exposure, particularly broad-spectrum or repeated courses
• Chronic stress. Cortisol increases intestinal permeability, slows motility, and reduces stomach acid
• Low stomach acid, often from chronic PPI use or aging
• Food sensitivities and chronic immune activation against ingested proteins
• Specific infections. SIBO, H. pylori, parasitic infections, candida overgrowth
• Medication effects. PPIs (proton pump inhibitors, the acid-blocking drugs), NSAIDs, antibiotics, steroids, opioids
• Diet patterns low in fiber and high in ultra-processed foods
• Environmental toxins and chronic exposures
• Chronic inflammation from any source

These drivers often co-occur. A patient with low stomach acid from chronic PPI use, on top of antibiotic exposure for repeated UTIs, on top of high stress, often has multiple gut issues at once.

Is a microbiome test worth doing, and who orders one?

A consumer microbiome test can show which organisms are present in a stool sample and in roughly what proportions; it cannot yet diagnose a condition, and the evidence that its scores and food lists change health outcomes is early. Sequencing the DNA or RNA in a sample gives a snapshot of the community on that day, and the community shifts with diet, sleep, travel, medication and illness. The thin step is from snapshot to verdict: there is no agreed definition of a healthy microbiome to score against, and when an international expert panel reviewed microbiome testing in clinical practice, it found the evidence for clinical usefulness scarce and no proven value yet for direct-to-consumer tests [PMID: 39647502].

Reproducibility is the other open question. When a standards laboratory sent the same reference stool material to seven consumer services, the results differed as much between companies as they would between two different people [PMID: 41748906], and a European expert workshop that ran one sample through six services judged the reports’ recommendations premature and of limited clinical use [PMID: 39695869]. None of this makes a report worthless. It makes a score a hypothesis rather than a finding, and a hypothesis is something a physician can work with.

The companies describe themselves plainly: Viome offers an at-home test to “measure your health down to the molecular level” with personalized food recommendations, and ZOE calls itself “a gut health science company that turns world-leading science into everyday gut-health products.” What a physician does with either kind of report is read it next to the history and the symptoms and ask whether anything in it would change the plan; usually it raises a question that a clinical test can settle. A comprehensive stool analysis ordered through a physician overlaps with the consumer reports in what it sequences, adds markers of digestion, inflammation and infection, and is read by someone accountable for the plan.

Clinical stool testing is a different category. It is ordered by primary care physicians, internists and gastroenterologists, it runs through accredited laboratories, and each test answers a defined question. Fecal calprotectin, a marker of inflammation in the bowel wall, helps rule out inflammatory bowel disease, and the American College of Gastroenterology suggests checking it in anyone with suspected IBS and diarrhea [PMID: 33315591]. Stool pathogen panels look for infection after travel, antibiotics or a sudden change in bowel habit; a stool antigen test checks for H. pylori; fecal elastase measures pancreatic enzyme output; and a stool blood test is part of colorectal cancer screening. Blood in the stool, unintended weight loss, fever, or pain or diarrhea that wakes someone at night are reasons to seek prompt medical care, whatever a report says.

The deeper picture

Gut symptoms are often dismissed or treated symptomatically when they're actually pointing toward identifiable, treatable patterns. A comprehensive workup including microbiome assessment, structural integrity markers, and pathogen screening typically reveals what's driving the picture. Extend works with patients on this kind of systematic investigation as part of precision medicine care.